Central Garden & Pet
Central Garden & Pet Company
Key figures
Period 2024-09-29 to 2025-09-27ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.1B
Operating marginCalculated
8.0%
Net assets to total assetsCalculated
43.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★☆☆position among all companies
8.0%
Growth (revenue, 4-year average)
★☆☆☆☆position among all companies
-1.3%
Capital efficiency
★★★☆☆position among all companies
10.3%
Revenue and profit
Performance, financial position and capital allocation
Central Garden & Pet
Recent performance trends
Central Garden & Pet
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$3.3 billion | US$3.3 billion | US$3.3 billion | US$3.2 billion | US$3.1 billion |
| Operating income | US$0.3 billion | US$0.3 billion | US$0.2 billion | US$0.2 billion | US$0.3 billion |
| Net income | US$0.2 billion | US$0.2 billion | US$0.1 billion | US$0.1 billion | US$0.2 billion |
| Total assets | US$3.1 billion | US$3.3 billion | US$3.4 billion | US$3.6 billion | US$3.6 billion |
| Shareholders' equity | US$1.2 billion | US$1.3 billion | US$1.5 billion | US$1.6 billion | US$1.6 billion |
| Net cash provided by (used in) operating activities | US$0.3 billion | US$-34.03 million | US$0.4 billion | US$0.4 billion | US$0.3 billion |
| Net cash provided by (used in) investing activities | US$-0.9 billion | US$-0.1 billion | US$-34.58 million | US$-0.1 billion | US$-44.89 million |
| Net cash provided by (used in) financing activities | US$0.4 billion | US$-66.81 million | US$-37.55 million | US$-25.44 million | US$-0.2 billion |
| Cash and cash equivalents | US$0.4 billion | US$0.2 billion | US$0.5 billion | US$0.8 billion | US$0.9 billion |
Revenue scale in the same industry
Central Garden & Pet
Wholesale (nondurable goods): 16 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 McKESSONFY Mar 2026 US$403.4B
- 2 CencoraFY Sep 2025 US$321.3B
- 3 Cardinal HealthFY Jun 2026 US$254.2B
- … 10 companies
- 14 CHEFS’ WarehouseFY Dec 2025 US$4.1B
- 15 Crossamerica Partners LPFY Dec 2025 US$3.7B
- 16 Central Garden & PetThis companyFY Sep 2025 US$3.1B
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$41.42 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.9 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-44.89 million | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.3 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$84.89 million | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$1.6 billion | Consolidated | Disclosed |
| Non-controlling interests | US$1.67 million | Consolidated | Disclosed |
| Net assets | US$1.6 billion | Consolidated | Disclosed |
| Net sales | US$3.1 billion | Consolidated | Disclosed |
| Operating income | US$0.3 billion | Consolidated | Disclosed |
| Net income | US$0.2 billion | Consolidated | Disclosed |
| Total assets | US$3.6 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.2 billion | Consolidated | Disclosed |
| Operating margin | 8.0% | Consolidated | Calculated |
| Net assets to total assets | 43.7% | Consolidated | Calculated |
| Net margin | 5.2% | Consolidated | Calculated |
| Return on equity | 10.3% | Consolidated | Calculated |